Erik Imel

  • 2080 Citations
  • 22 h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Erik Imel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Familial Hypophosphatemic Rickets Medicine & Life Sciences
Phosphates Medicine & Life Sciences
Hypophosphatemia Medicine & Life Sciences
Calcinosis Medicine & Life Sciences
Rickets Medicine & Life Sciences
Serum Medicine & Life Sciences
Mutation Medicine & Life Sciences
Phosphorus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 2009 2015

Familial Hypophosphatemic Rickets
Phosphates
Pediatrics
Calcitriol
Therapeutics

Publications 2005 2019

  • 2080 Citations
  • 22 h-Index
  • 48 Article
  • 5 Chapter
  • 1 Review article
2 Citations (Scopus)

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Imel, E., Glorieux, F. H., Whyte, M. P., Munns, C. F., Ward, L. M., Nilsson, O., Simmons, J. H., Padidela, R., Namba, N., Cheong, H. I., Pitukcheewanont, P., Sochett, E., Högler, W., Muroya, K., Tanaka, H., Gottesman, G. S., Biggin, A., Perwad, F., Mao, M., Chen, C. Y. & 3 others, Skrinar, A., San Martin, J. & Portale, A. A., Jun 15 2019, In : The Lancet. 393, 10189, p. 2416-2427 12 p.

Research output: Contribution to journalArticle

Rickets
Group Psychotherapy
Therapeutics
PHEX Phosphate Regulating Neutral Endopeptidase
Research Personnel
1 Citation (Scopus)

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Portale, A. A., Carpenter, T. O., Brandi, M. L., Briot, K., Cheong, H. I., Cohen-Solal, M., Crowley, R., Jan De Beur, S., Eastell, R., Imanishi, Y., Imel, E., Ing, S., Ito, N., Javaid, M., Kamenicky, P., Keen, R., Kubota, T., Lachmann, R., Perwad, F., Pitukcheewanont, P. & 10 others, Ralston, S. H., Takeuchi, Y., Tanaka, H., Weber, T. J., Yoo, H. W., Zhang, L., Theodore-Oklota, C., Mealiffe, M., San Martin, J. & Insogna, K., Jan 1 2019, In : Calcified Tissue International.

Research output: Contribution to journalArticle

Open Access
Familial Hypophosphatemic Rickets
Placebos
Phosphorus
Nephrocalcinosis
Inborn Genetic Diseases
7 Citations (Scopus)

Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

Whyte, M. P., Carpenter, T. O., Gottesman, G. S., Mao, M., Skrinar, A., San Martin, J. & Imel, E., Mar 1 2019, In : The Lancet Diabetes and Endocrinology. 7, 3, p. 189-199 11 p.

Research output: Contribution to journalArticle

Rickets
Safety
Phosphorus
Serum
Least-Squares Analysis

FGF23 and Associated Disorders of Phosphate Wasting

Gohil, A. & Imel, E. A., Sep 1 2019, In : Pediatric endocrinology reviews : PER. 17, 1, p. 17-34 18 p.

Research output: Contribution to journalReview article

Familial Hypophosphatemic Rickets
Phosphates
Phosphorus
Kidney
Hypophosphatemic Rickets

Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients

DeLacey, S., Liu, Z., Broyles, A., El-Azab, S. A., Guandique, C. F., James, B. C. & Imel, E., Oct 1 2019, In : Bone. 127, p. 386-392 7 p.

Research output: Contribution to journalArticle

Familial Hypophosphatemic Rickets
Parathyroidectomy
Hyperparathyroidism
Nephrocalcinosis
Secondary Hyperparathyroidism